Qiagen Starts Marketing Own Diagnostic Agents In Japan
This article was originally published in PharmAsia News
Executive Summary
German diagnostics maker Qiagen started marketing three diagnostic agents and two samplers in Japan. The three diagnostics agents use proprietary Hybrid Capture for human papillomavirus, chlamydia and gonococci DNA tests; the company also launched samplers for HPV and other sexually transmitted diseases. Previously, Qiagen products were marketed through Tokyo-based Mitsubishi Chemical Medicine. Qiagen Japanese subsidiary last year obtained the marketing approval and it is now co-promoting HPV products with Mitsubishi. Qiagen Japan has less than 20 sales representatives and the company plans to increase that number as its own marketing operations takes off. (Click here for more - Japanese language